TY - JOUR AU - Kim, D. W. AU - Patel, S. P. PY - 2014 DA - 2014// TI - Profile of selumetinib and its potential in the treatment of melanoma JO - Onco Targets Ther VL - 7 ID - Kim2014 ER - TY - JOUR AU - Shain, A. H. AU - Bastian, B. C. PY - 2016 DA - 2016// TI - From melanocytes to melanomas JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.37 DO - 10.1038/nrc.2016.37 ID - Shain2016 ER - TY - JOUR AU - Ma, C. AU - Armstrong, A. W. PY - 2014 DA - 2014// TI - Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2 JO - J Dermatolog Treat VL - 25 UR - https://doi.org/10.3109/09546634.2013.813897 DO - 10.3109/09546634.2013.813897 ID - Ma2014 ER - TY - JOUR AU - Chidambaram, M. AU - Manavalan, R. AU - Kathiresan, K. PY - 2011 DA - 2011// TI - Nanotherapeutics to overcome conventional cancer chemotherapy limitations JO - J Pharm Pharm Sci VL - 14 UR - https://doi.org/10.18433/J30C7D DO - 10.18433/J30C7D ID - Chidambaram2011 ER - TY - JOUR AU - Katsumata, N. AU - Yasuda, M. AU - Isonishi, S. AU - Takahashi, F. AU - Michimae, H. AU - Kimura, E. AU - Aoki, D. AU - Jobo, T. AU - Kodama, S. AU - Terauchi, F. AU - Sugiyama, T. AU - Ochiai, K. PY - 2013 DA - 2013// TI - Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70363-2 DO - 10.1016/S1470-2045(13)70363-2 ID - Katsumata2013 ER - TY - JOUR AU - Wang, T. AU - Liu, Y. AU - Wu, C. PY - 2017 DA - 2017// TI - Effect of paclitaxel-mesoporous silica nanoparticles with a core-shell structure on the human lung cancer cell line A549 JO - Nanoscale Res Lett VL - 12 UR - https://doi.org/10.1186/s11671-017-1826-1 DO - 10.1186/s11671-017-1826-1 ID - Wang2017 ER - TY - JOUR AU - Hu, L. AU - Hofmann, J. AU - Lu, Y. AU - Mills, G. B. AU - Jaffe, R. B. PY - 2002 DA - 2002// TI - Inhibition of phosphatidylinositol 3′-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models JO - Cancer Res VL - 62 ID - Hu2002 ER - TY - JOUR AU - Lv, S. AU - Tang, Z. AU - Li, M. AU - Lin, J. AU - Song, W. AU - Liu, H. AU - Huang, Y. AU - Zhang, Y. AU - Chen, X. PY - 2014 DA - 2014// TI - Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer JO - Biomaterials VL - 35 UR - https://doi.org/10.1016/j.biomaterials.2014.04.034 DO - 10.1016/j.biomaterials.2014.04.034 ID - Lv2014 ER - TY - JOUR AU - Komiya, K. AU - Nakamura, T. AU - Nakashima, C. AU - Takahashi, K. AU - Umeguchi, H. AU - Watanabe, N. AU - Sato, A. AU - Takeda, Y. AU - Kimura, S. AU - Sueoka-Aragane, N. PY - 2016 DA - 2016// TI - sParc is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer JO - Onco Targets Ther VL - 9 UR - https://doi.org/10.2147/OTT.S114492 DO - 10.2147/OTT.S114492 ID - Komiya2016 ER - TY - JOUR AU - Azzarito, T. AU - Venturi, G. AU - Cesolini, A. AU - Fais, S. PY - 2015 DA - 2015// TI - Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma JO - Cancer Lett VL - 356 UR - https://doi.org/10.1016/j.canlet.2014.10.017 DO - 10.1016/j.canlet.2014.10.017 ID - Azzarito2015 ER - TY - JOUR AU - Wilson, M. A. AU - Zhao, F. AU - Khare, S. AU - Roszik, J. AU - Woodman, S. E. AU - D'Andrea, K. AU - Wubbenhorst, B. AU - Rimm, D. L. AU - Kirkwood, J. M. AU - Kluger, H. M. AU - Schuchter, L. M. AU - Lee, S. J. AU - Flaherty, K. T. AU - Nathanson, K. L. PY - 2016 DA - 2016// TI - Copy number changes are associated with response to treatment with carboplatin, paclitaxel, and sorafenib in melanoma JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1162 DO - 10.1158/1078-0432.CCR-15-1162 ID - Wilson2016 ER - TY - JOUR AU - Szebeni, J. AU - Alving, C. R. AU - Muggia, F. M. PY - 1998 DA - 1998// TI - Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study JO - J Natl Cancer Inst VL - 90 UR - https://doi.org/10.1093/jnci/90.4.300 DO - 10.1093/jnci/90.4.300 ID - Szebeni1998 ER - TY - JOUR AU - Šmejkalová, D. AU - Nešporová, K. AU - Hermannová, M. AU - Huerta-Angeles, G. AU - Cožíková, D. AU - Vištejnová, L. AU - Safránková, B. AU - Novotný, J. AU - Kučerík, J. AU - Velebný, V. PY - 2014 DA - 2014// TI - Paclitaxel isomerisation in polymeric micelles based on hydrophobized hyaluronic acid JO - Int J Pharm VL - 466 UR - https://doi.org/10.1016/j.ijpharm.2014.03.024 DO - 10.1016/j.ijpharm.2014.03.024 ID - Šmejkalová2014 ER - TY - JOUR AU - Zhang, F. AU - Zhang, S. AU - Pollack, S. F. AU - Li, R. AU - Gonzalez, A. M. AU - Fan, J. AU - Zou, J. AU - Leininger, S. E. AU - Pavía-Sanders, A. AU - Johnson, R. AU - Nelson, L. D. AU - Raymond, J. E. AU - Elsabahy, M. AU - Hughes, D. M. AU - Lenox, M. W. AU - Gustafson, T. P. AU - Wooley, K. L. PY - 2015 DA - 2015// TI - Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers JO - J Am Chem Soc VL - 137 UR - https://doi.org/10.1021/ja512616s DO - 10.1021/ja512616s ID - Zhang2015 ER - TY - JOUR AU - Xu, Z. AU - Wang, S. AU - Li, Y. AU - Wang, M. AU - Shi, P. AU - Huang, X. PY - 2014 DA - 2014// TI - Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel JO - ACS Appl Mater Interfaces VL - 6 UR - https://doi.org/10.1021/am505308f DO - 10.1021/am505308f ID - Xu2014 ER - TY - JOUR AU - Costanzo, F. AU - Gasperoni, S. AU - Rotella, V. AU - Costanzo, F. PY - 2009 DA - 2009// TI - Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer JO - Onco Targets Ther VL - 2 UR - https://doi.org/10.2147/OTT.S3863 DO - 10.2147/OTT.S3863 ID - Costanzo2009 ER - TY - JOUR AU - Danhier, F. AU - Feron, O. AU - Préat, V. PY - 2010 DA - 2010// TI - To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery JO - J Control Release VL - 148 UR - https://doi.org/10.1016/j.jconrel.2010.08.027 DO - 10.1016/j.jconrel.2010.08.027 ID - Danhier2010 ER - TY - JOUR AU - Paulos, C. M. AU - Turk, M. J. AU - Breur, G. J. AU - Low, P. S. PY - 2004 DA - 2004// TI - Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis JO - Adv Drug Deliv Rev VL - 56 UR - https://doi.org/10.1016/j.addr.2004.01.012 DO - 10.1016/j.addr.2004.01.012 ID - Paulos2004 ER - TY - JOUR AU - Pérez-Herrero, E. AU - Fernández-Medarde, A. PY - 2015 DA - 2015// TI - Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy JO - Eur J Pharm Biopharm VL - 93 UR - https://doi.org/10.1016/j.ejpb.2015.03.018 DO - 10.1016/j.ejpb.2015.03.018 ID - Pérez-Herrero2015 ER - TY - STD TI - Cook BE. The use of radioactive nanoparticles for the diagnosis and treatment of cancer. The Alfred University 2014. https://aura.alfred.edu/handle/10829/5910. UR - https://aura.alfred.edu/handle/10829/5910 ID - ref20 ER - TY - JOUR AU - Unak, P. AU - Cetinkaya, B. PY - 2005 DA - 2005// TI - Absorbed dose estimates at the cellular level for 131I JO - Appl Radiat Isot VL - 62 UR - https://doi.org/10.1016/j.apradiso.2004.07.013 DO - 10.1016/j.apradiso.2004.07.013 ID - Unak2005 ER - TY - JOUR AU - Yi, X. AU - Yang, K. AU - Liang, C. AU - Zhong, X. AU - Ning, P. AU - Song, G. AU - Wang, D. AU - Ge, C. AU - Chen, C. AU - Chai, Z. AU - Liu, Z. PY - 2015 DA - 2015// TI - Imaging-guided combined photothermal and radiotherapy to treat subcutaneous and metastatic tumors using iodine-131-doped copper sulfide nanoparticles JO - Adv Funct Mater VL - 25 UR - https://doi.org/10.1002/adfm.201502003 DO - 10.1002/adfm.201502003 ID - Yi2015 ER - TY - JOUR AU - Xin, Y. AU - Liu, T. AU - Yang, C. PY - 2016 DA - 2016// TI - Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery JO - Int J Nanomedicine VL - 11 UR - https://doi.org/10.2147/IJN.S119999 DO - 10.2147/IJN.S119999 ID - Xin2016 ER - TY - JOUR AU - Gao, J. AU - Fang, L. AU - Sun, D. AU - Shen, Y. AU - Hu, Y. AU - Li, N. AU - Chang, J. AU - Li, W. AU - Tan, J. PY - 2016 DA - 2016// TI - 131I-labeled and DOX-loaded multifunctional nanoliposomes for radiotherapy and chemotherapy in brain gliomas JO - Brain Res ID - Gao2016 ER - TY - JOUR AU - Akman, L. AU - Muftuler, F. Z. B. AU - Bilgi, A. AU - Kilcar, A. Y. AU - Gokulu, S. G. AU - Medine, E. I. AU - Terek, M. C. PY - 2016 DA - 2016// TI - Synthesis of a theranostic agent: radioiodinated PEGylated PLGA-indocyanine capsules and in vitro determination of their bioaffinity on ovarian, cervical and breast cancer cells JO - J Radioanal Nucl Chem VL - 308 UR - https://doi.org/10.1007/s10967-015-4472-z DO - 10.1007/s10967-015-4472-z ID - Akman2016 ER - TY - JOUR AU - Danhier, F. AU - Ansorena, E. AU - Silva, J. M. AU - Coco, R. AU - Breton, A. AU - Préat, V. PY - 2012 DA - 2012// TI - PLGA-based nanoparticles: an overview of biomedical applications JO - J Control Release VL - 161 UR - https://doi.org/10.1016/j.jconrel.2012.01.043 DO - 10.1016/j.jconrel.2012.01.043 ID - Danhier2012 ER - TY - JOUR AU - Shokeen, M. AU - Fettig, N. M. AU - Rossin, R. PY - 2008 DA - 2008// TI - Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles JO - Q J Nucl Med Mol Imaging VL - 52 ID - Shokeen2008 ER - TY - JOUR AU - Yang, K. AU - Wan, J. AU - Zhang, S. AU - Tian, B. AU - Zhang, Y. AU - Liu, Z. PY - 2012 DA - 2012// TI - The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power JO - Biomaterials VL - 33 UR - https://doi.org/10.1016/j.biomaterials.2011.11.064 DO - 10.1016/j.biomaterials.2011.11.064 ID - Yang2012 ER - TY - JOUR AU - Liu, Z. AU - Chen, K. AU - Davis, C. AU - Sherlock, S. AU - Cao, Q. AU - Chen, X. AU - Dai, H. PY - 2008 DA - 2008// TI - Drug delivery with carbon nanotubes for in vivo cancer treatment JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-1468 DO - 10.1158/0008-5472.CAN-08-1468 ID - Liu2008 ER - TY - JOUR AU - Torchilin, V. PY - 2011 DA - 2011// TI - Tumor delivery of macromolecular drugs based on the EPR effect JO - Adv Drug Deliv Rev VL - 63 UR - https://doi.org/10.1016/j.addr.2010.03.011 DO - 10.1016/j.addr.2010.03.011 ID - Torchilin2011 ER - TY - JOUR AU - Gabizon, A. A. PY - 1995 DA - 1995// TI - Liposome circulation time and tumor targeting: implications for cancer chemotherapy JO - Adv Drug Deliv Rev VL - 16 UR - https://doi.org/10.1016/0169-409X(95)00030-B DO - 10.1016/0169-409X(95)00030-B ID - Gabizon1995 ER - TY - JOUR AU - Kulkarni, S. A. AU - Feng, S. S. PY - 2013 DA - 2013// TI - Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery JO - Pharm Res VL - 30 UR - https://doi.org/10.1007/s11095-012-0958-3 DO - 10.1007/s11095-012-0958-3 ID - Kulkarni2013 ER - TY - JOUR AU - Wang, J. AU - Xie, Y. AU - Wang, L. AU - Tang, J. AU - Li, J. AU - Kocaefe, D. AU - Kocaefe, Y. AU - Zhang, Z. AU - Li, Y. AU - Chen, C. PY - 2015 DA - 2015// TI - In vivo pharmacokinetic features and biodistribution of star and rod shaped gold nanoparticles by multispectral optoacoustic tomography JO - RSC Adv VL - 5 UR - https://doi.org/10.1039/C4RA13228A DO - 10.1039/C4RA13228A ID - Wang2015 ER -